Tianda Pharmaceuticals Ltd. (HK:0455) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Tianda Pharmaceuticals Ltd. has announced its wholly-owned subsidiary received approval from China’s National Medical Products Administration for an ibuprofen suspension for children. The new product is expected to enhance the company’s pediatric portfolio and market presence. This development is part of Tianda’s strategic growth, with seven new products anticipated to launch in the next two years.
For further insights into HK:0455 stock, check out TipRanks’ Stock Analysis page.